Top compounds associated with response to USP17L1


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.4
mRNA Crizotinib gCSI pan-cancer AAC -0.043 0.4
mRNA SKI-II CTRPv2 pan-cancer AAC 0.028 0.4
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.026 0.4
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.4
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.4
mRNA AZD6244 UHNBreast pan-cancer AAC 0.23 0.4
mRNA indisulam CTRPv2 pan-cancer AAC 0.024 0.4
mRNA bendamustine CTRPv2 pan-cancer AAC 0.029 0.4
Download CSV